Navigation Links
NIH answers call to streamline technology transfer process
Date:11/28/2011

The National Institutes of Health is launching the electronic Research Materials catalogue (eRMa) to streamline the federal government's technology transfer process. This project addresses one of the important directives in a Presidential memorandum related to the commercialization of federal research and support for high-growth business potential. eRMa was designed and developed by the Office of Technology Transfer (OTT) at NIH with support from the NIH's National Cancer Institute Center for Cancer Research.

More than 6,000 researchers at NIH laboratories help to drive the research and discovery process. These NIH researchers make unpatented materials available to companies through internal use licenses executed by the OTT to support the continued advancement of scientific research. Examples of materials include mouse models used to develop new cancer therapies and cell lines used to test new therapies for chronic diseases, such as high blood pressure. An NIH internal use license is a contract that governs the transfer of tangible research materials from NIH to a company for commercial research use.

The new system will streamline the licensing process by:

  • Providing a website for companies to find and license unpatented materials using a ready-to-go contract.
  • Allowing a company to pay online through Pay.gov and receive the materials from the lab quickly.
  • Providing faster turn-around time and simplifying the process for companies to find research materials available from NIH labs.

"To stay competitive in today's world, on-line ordering is a requirement. With the launch of this first-of-its kind system, OTT is demonstrating its intention to meet that challenge," said Mark Rohrbaugh, director of OTT.

For non-profit research organizations interested in obtaining NIH materials through a material transfer agreement, the NIH will launch the Transfer Agreement Dashboard in December. This web-based system will have a broad array of beneficiaries including NIH scientists and technology transfer staff as well as researchers and technology transfer offices at universities and non-profit research institutions.


'/>"/>

Contact: Bonny Harbinger
harbinger@nih.gov
301-594-7700
NIH/Office of the Director
Source:Eurekalert

Related biology news :

1. New supercomputer to reel in answers to some of Earths problems
2. Aurora B answers an XIST-ential question
3. Researcher looks for answers about unique disease-resistant gene
4. Studying hair of ancient Peruvians answers questions about stress
5. LSUHSC pediatric weight expert provides obesity trinity answers
6. Swine researchers seek answers to fibers low digestibility
7. What is life? New answers to an age-old question in astrobiology
8. Bacterial genome may hold answers to mercury mystery
9. Penn research answers long-standing question about swimming in elastic liquids
10. Study shows answers for treating obesity-related diseases may reside in fat tissue
11. UofL students seek answers to breast cancer disparities in minority populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. ... "Eating Well Made Simple," and 23andMe , the ... guide better food choices.  Zipongo can now provide customers ... food preferences, health goals and biometrics, but also genetic ... food choices. Zipongo,s personalized food decision support ...
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
(Date:3/23/2017)... New York , March 23, 2017 ... blood plasma products and derivatives market is fragmented due to the presence ... players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete ... leader, these three companies, collectively, held more than 76% of this ... ...
(Date:3/23/2017)... YORK , March 23, 2017 ... look at four equities in the Biotech industry: Sangamo ... Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics ... 21 st , 2017, Credit Suisse upgraded its rating on ... by downloading their free report at: ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
Breaking Biology Technology: